Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Edronax, Norebox, Solvex, Vestra
Reboxetine is a selective norepinephrine reuptake inhibitor (SNRI) primarily used to treat major depressive disorder (MDD). It works by increasing the levels of norepinephrine, a neurotransmitter in the brain believed to play a role in mood regulation. Reboxetine is a small molecule drug.
For the treatment of major depressive disorder (MDD).
Outcome:
Serotonin syndrome
Mechanism:
Increased serotonin levels
Outcome:
Increased reboxetine levels
Mechanism:
Inhibition of reboxetine metabolism
Outcome:
Decreased reboxetine absorption
Mechanism:
Binding of reboxetine in the GI tract
Most likely new formulation: Extended-release formulation (2025, 30% confidence)
Based on its efficacy and safety profile, there is a low probability of FDA approval for new indications in the near future.
Antidepressant, Selective Norepinephrine Reuptake Inhibitor (SNRI)
Morpholine derivative